A biotech company that after much turmoil and huge expense launched the first human embryonic stem cell clinical trial in the United States is getting out of the stem cell business.
A patient with a spinal cord injury was injected with human stem cells—marking the start of the first clinical trial of a human stem-cell therapy, one that could potentially help paralyzed people walk and control certain bodily functions.
This is Sarah May Scott. She got a grave spinal cord injury in 2005. And if everything goes well, she may start walking again: